CD8A and neoplasm: Further, the tumor-infiltrating CD8+ T cells in the Lm-LLO-CD105A treated group showed an effector phenotype as marked by an elevated population of CD8+CD62L lo cells in the orthotopic model (Supplementary Figure S4C).